Stockreport

Maze Therapeutics to Participate in the Guggenheim Emerging Outlook: Biotech Summit 2026

Maze Therapeutics, Inc.  (MAZE) 
PDF SOUTH SAN FRANCISCO, Calif., Feb. 04, 2026 (GLOBE NEWSWIRE) -- Maze Therapeutics, Inc. (Nasdaq: MAZE), a clinical-stage biopharmaceutical company developing small mole [Read more]